Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment

J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1778-1780.e1. doi: 10.1016/j.jaip.2018.01.034. Epub 2018 Feb 9.

Authors

Andreas Wollenberg¹, Lieneke Ariens², Stephan Thurau³, Chantal van Luijk⁴, Marlene Seegräber⁵, Marjolein de Bruin-Weller²

Affiliations

¹ Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany. Electronic address: wollenberg@lrz.uni-muenchen.de.
² Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
³ Department of Ophthalmology, Ludwig-Maximilian University, Munich, Germany.
⁴ Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.
⁵ Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany.

PMID: 29432961
DOI: 10.1016/j.jaip.2018.01.034

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Conjunctivitis / diagnosis*
Conjunctivitis / etiology
Conjunctivitis / prevention & control
Dermatitis, Atopic / drug therapy*
Drug-Related Side Effects and Adverse Reactions / diagnosis*
Drug-Related Side Effects and Adverse Reactions / prevention & control
Female
Fluorometholone / administration & dosage
Humans
Hyperemia
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use*
Limbus Corneae / pathology*
Male
Middle Aged
Receptors, Interleukin-4 / antagonists & inhibitors
Tacrolimus / administration & dosage

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Immunosuppressive Agents
Receptors, Interleukin-4
dupilumab
Fluorometholone
Tacrolimus